Standout Papers

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin 2014 2026 2018 2022 680
  1. Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin (2014)
    Jordan J. Feld, Kris V. Kowdley et al. New England Journal of Medicine
  2. ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis (2014)
    Fred Poordad, Christophe Hézode et al. New England Journal of Medicine
  3. Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin (2014)
    Stefan Zeuzem, Ira M. Jacobson et al. New England Journal of Medicine

Immediate Impact

7 by Nobel laureates 3 from Science/Nature 66 standout
Sub-graph 1 of 16

Citing Papers

Principles and therapeutic applications of adaptive immunity
2024 Standout
Cancer vaccines: Building a bridge over troubled waters
2022 Standout
1 intermediate paper

Works of Thomas Podsadecki being referenced

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
2014 Standout

Author Peers

Author Last Decade Papers Cites
Thomas Podsadecki 3374 1584 2958 72 4.1k
Dennis M. Grasela 1716 1423 2180 87 4.3k
William T. Symonds 4099 1181 3723 87 4.8k
Vincent Di Martino 4083 805 3984 141 5.5k
Marina Núñez 2378 1473 2299 107 3.4k
Stefan Mauss 4193 1647 3988 188 5.3k
Monika Peeters 2277 2417 2325 61 4.2k
David Wong 3576 548 3637 123 5.4k
Hartwig Klinker 1273 1082 1601 156 2.9k
Pablo Labarga 2059 1916 2104 134 3.7k
Eugenia Vispo 1846 1111 1710 100 2.8k

All Works

Loading papers...

Rankless by CCL
2026